Dealmakers at the largest technology and life science firms in Silicon Valley finished the first half of 2023 on a disappointing streak, with M&A and investment activity remaining far below where it was at the start of 2022.
The dreadful fall in M&A activity nationwide since the beginning of last year has been the talk of dealmaking circles. So it comes as no surprise to see a corresponding plunge in the number and value of M&A and investment deals involving the members of the newly released 2023 Fenwick-Bloomberg Law SV 150 List, which ranks the 150 largest publicly traded ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.